Towards small molecule inhibitors of mono-ADP-ribosyltransferases
(2015) In European Journal of Medicinal Chemistry 95. p.51-546- Abstract
Protein ADP-ribosylation is a post-translational modification involved in DNA repair, protein degradation, transcription regulation, and epigenetic events. Intracellular ADP-ribosylation is catalyzed predominantly by ADP-ribosyltransferases with diphtheria toxin homology (ARTDs). The most prominent member of the ARTD family, poly(ADP-ribose) polymerase-1 (ARTD1/PARP1) has been a target for cancer drug development for decades. Current PARP inhibitors are generally non-selective, and inhibit the mono-ADP-ribosyltransferases with low potency. Here we describe the synthesis of acylated amino benzamides and screening against the mono-ADP-ribosyltransferases ARTD7/PARP15, ARTD8/PARP14, ARTD10/PARP10, and the poly-ADP-ribosyltransferase... (More)
Protein ADP-ribosylation is a post-translational modification involved in DNA repair, protein degradation, transcription regulation, and epigenetic events. Intracellular ADP-ribosylation is catalyzed predominantly by ADP-ribosyltransferases with diphtheria toxin homology (ARTDs). The most prominent member of the ARTD family, poly(ADP-ribose) polymerase-1 (ARTD1/PARP1) has been a target for cancer drug development for decades. Current PARP inhibitors are generally non-selective, and inhibit the mono-ADP-ribosyltransferases with low potency. Here we describe the synthesis of acylated amino benzamides and screening against the mono-ADP-ribosyltransferases ARTD7/PARP15, ARTD8/PARP14, ARTD10/PARP10, and the poly-ADP-ribosyltransferase ARTD1/PARP1. The most potent compound inhibits ARTD10 with sub-micromolar IC50.
(Less)
- author
- Ekblad, Torun
; Lindgren, Anders E G
; Andersson, C David
; Caraballo, Rémi
; Thorsell, Ann-Gerd
; Karlberg, Tobias
LU
; Spjut, Sara
; Linusson, Anna
; Schüler, Herwig
LU
and Elofsson, Mikael
- publishing date
- 2015-05-05
- type
- Contribution to journal
- publication status
- published
- keywords
- ADP Ribose Transferases/antagonists & inhibitors, Drug Evaluation, Preclinical, Enzyme Inhibitors/pharmacology, Humans, Inhibitory Concentration 50, Small Molecule Libraries/pharmacology
- in
- European Journal of Medicinal Chemistry
- volume
- 95
- pages
- 6 pages
- publisher
- Elsevier Masson SAS
- external identifiers
-
- pmid:25847771
- scopus:84926206190
- ISSN
- 0223-5234
- DOI
- 10.1016/j.ejmech.2015.03.067
- language
- English
- LU publication?
- no
- additional info
- Copyright © 2015 The Authors. Published by Elsevier Masson SAS.. All rights reserved.
- id
- 864d52f5-9c8d-4782-9155-37ee0b2cd542
- date added to LUP
- 2024-11-21 17:54:02
- date last changed
- 2025-06-20 21:11:44
@article{864d52f5-9c8d-4782-9155-37ee0b2cd542, abstract = {{<p>Protein ADP-ribosylation is a post-translational modification involved in DNA repair, protein degradation, transcription regulation, and epigenetic events. Intracellular ADP-ribosylation is catalyzed predominantly by ADP-ribosyltransferases with diphtheria toxin homology (ARTDs). The most prominent member of the ARTD family, poly(ADP-ribose) polymerase-1 (ARTD1/PARP1) has been a target for cancer drug development for decades. Current PARP inhibitors are generally non-selective, and inhibit the mono-ADP-ribosyltransferases with low potency. Here we describe the synthesis of acylated amino benzamides and screening against the mono-ADP-ribosyltransferases ARTD7/PARP15, ARTD8/PARP14, ARTD10/PARP10, and the poly-ADP-ribosyltransferase ARTD1/PARP1. The most potent compound inhibits ARTD10 with sub-micromolar IC50.</p>}}, author = {{Ekblad, Torun and Lindgren, Anders E G and Andersson, C David and Caraballo, Rémi and Thorsell, Ann-Gerd and Karlberg, Tobias and Spjut, Sara and Linusson, Anna and Schüler, Herwig and Elofsson, Mikael}}, issn = {{0223-5234}}, keywords = {{ADP Ribose Transferases/antagonists & inhibitors; Drug Evaluation, Preclinical; Enzyme Inhibitors/pharmacology; Humans; Inhibitory Concentration 50; Small Molecule Libraries/pharmacology}}, language = {{eng}}, month = {{05}}, pages = {{51--546}}, publisher = {{Elsevier Masson SAS}}, series = {{European Journal of Medicinal Chemistry}}, title = {{Towards small molecule inhibitors of mono-ADP-ribosyltransferases}}, url = {{http://dx.doi.org/10.1016/j.ejmech.2015.03.067}}, doi = {{10.1016/j.ejmech.2015.03.067}}, volume = {{95}}, year = {{2015}}, }